These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28119366)

  • 1. Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALL.
    Jones L; Richmond J; Evans K; Carol H; Jing D; Kurmasheva RT; Billups CA; Houghton PJ; Smith MA; Lock RB
    Clin Cancer Res; 2017 Jul; 23(14):3744-3755. PubMed ID: 28119366
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice.
    Terziyska N; Castro Alves C; Groiss V; Schneider K; Farkasova K; Ogris M; Wagner E; Ehrhardt H; Brentjens RJ; zur Stadt U; Horstmann M; Quintanilla-Martinez L; Jeremias I
    PLoS One; 2012; 7(12):e52798. PubMed ID: 23300782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts.
    Szymanska B; Wilczynska-Kalak U; Kang MH; Liem NL; Carol H; Boehm I; Groepper D; Reynolds CP; Stewart CF; Lock RB
    PLoS One; 2012; 7(3):e33894. PubMed ID: 22479469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis.
    Niu G; Zhu L; Ho DN; Zhang F; Gao H; Quan Q; Hida N; Ozawa T; Liu G; Chen X
    Theranostics; 2013; 3(3):190-200. PubMed ID: 23471295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies.
    Dias JNR; André AS; Aguiar SI; Ministro J; Oliveira J; Peleteiro MC; Rütgen B; Gano L; Correia JDG; Oliveira SS; Goncalves J; Gil S; Tavares L; Aires-da-Silva F
    PLoS One; 2018; 13(12):e0208147. PubMed ID: 30592723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging.
    Thalheimer A; Korb D; Bönicke L; Wiegering A; Mühling B; Schneider M; Koch S; Riedel SS; Germer CT; Beilhack A; Brändlein S; Otto C
    J Surg Res; 2013 Nov; 185(1):143-51. PubMed ID: 23998649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
    Liu JF; Palakurthi S; Zeng Q; Zhou S; Ivanova E; Huang W; Zervantonakis IK; Selfors LM; Shen Y; Pritchard CC; Zheng M; Adleff V; Papp E; Piao H; Novak M; Fotheringham S; Wulf GM; English J; Kirschmeier PT; Velculescu VE; Paweletz C; Mills GB; Livingston DM; Brugge JS; Matulonis UA; Drapkin R
    Clin Cancer Res; 2017 Mar; 23(5):1263-1273. PubMed ID: 27573169
    [No Abstract]   [Full Text] [Related]  

  • 8. Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia.
    Alruwetei AM; Bendak K; Yadav BD; Carol H; Evans K; Mayoh C; Sutton R; Marshall GM; Lock RB
    Br J Cancer; 2020 Sep; 123(5):742-751. PubMed ID: 32536690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia.
    Xie J; Span M; van Maarseveen E; Langenhorst J; Boddy AV; Sia KCS; Sutton R; Venn N; Punt AM; Tyrrell V; Haber M; Trahair T; Lau L; Marshall GM; Lock RB
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28133. PubMed ID: 31876116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease.
    van der Bogt KE; Hellingman AA; Lijkwan MA; Bos EJ; de Vries MR; van Rappard JR; Fischbein MP; Quax PH; Robbins RC; Hamming JF; Wu JC
    JACC Cardiovasc Imaging; 2012 Jan; 5(1):46-55. PubMed ID: 22239892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.
    Jenkins DE; Oei Y; Hornig YS; Yu SF; Dusich J; Purchio T; Contag PR
    Clin Exp Metastasis; 2003; 20(8):733-44. PubMed ID: 14713107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
    Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
    Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioluminescence Imaging for Evaluation of Antitumor Effect In Vitro and In Vivo in Mice Xenografted Tumor Models.
    Sato K
    Methods Mol Biol; 2022; 2524():307-315. PubMed ID: 35821482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first Japanese biobank of patient-derived pediatric acute lymphoblastic leukemia xenograft models.
    Tanaka K; Kato I; Dobashi Y; Imai JI; Mikami T; Kubota H; Ueno H; Ito M; Ogawa S; Nakahata T; Takita J; Toyoda H; Ogawa C; Adachi S; Watanabe S; Goto H
    Cancer Sci; 2022 Nov; 113(11):3814-3825. PubMed ID: 35879192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles.
    Fazzina R; Lombardini L; Mezzanotte L; Roda A; Hrelia P; Pession A; Tonelli R
    Int J Oncol; 2012 Aug; 41(2):621-8. PubMed ID: 22665135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression.
    Bomken S; Buechler L; Rehe K; Ponthan F; Elder A; Blair H; Bacon CM; Vormoor J; Heidenreich O
    Leukemia; 2013 Mar; 27(3):718-21. PubMed ID: 22858908
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
    Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
    Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma.
    Maes W; Deroose C; Reumers V; Krylyshkina O; Gijsbers R; Baekelandt V; Ceuppens J; Debyser Z; Van Gool SW
    J Neurooncol; 2009 Jan; 91(2):127-39. PubMed ID: 18787761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-CD19 antibody-drug conjugate SAR3419 prevents hematolymphoid relapse postinduction therapy in preclinical models of pediatric acute lymphoblastic leukemia.
    Carol H; Szymanska B; Evans K; Boehm I; Houghton PJ; Smith MA; Lock RB
    Clin Cancer Res; 2013 Apr; 19(7):1795-805. PubMed ID: 23426279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human brainstem glioma xenograft model enabled for bioluminescence imaging.
    Hashizume R; Ozawa T; Dinca EB; Banerjee A; Prados MD; James CD; Gupta N
    J Neurooncol; 2010 Jan; 96(2):151-9. PubMed ID: 19585223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.